Utah Medical Products' stock decline is overblown, as margins remain intact and the balance sheet has substantial assets.

The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.

Have you ever been so laser-focused on a task—playing a video game, reading an engrossing book, and so on—that when you look ...